Vista Pharmaceuticals Limited has announced that its board of directors will meet on Friday, May 29, 2026. The meeting is scheduled to be held at the company's registered office in Hyderabad to discuss key financial matters.

The primary agenda for the meeting includes the consideration of the audited financial results for the quarter and year ended March 31, 2026. Additionally, the board will review the audit report for the corresponding period.

Any other business with the permission of the Chair may also be taken up during the meeting. The intimation was sent to the BSE Limited in compliance with SEBI regulations.

Meeting Details

The company has informed the stock exchange regarding the schedule and purpose of the board meeting. The outcomes of the deliberations will be disclosed following the conclusion of the meeting.

Vista Pharmaceuticals Limited has filed its quarterly compliance certificate with BSE Limited, confirming adherence to SEBI regulations for dematerialization processes during the quarter ended 31.03.2026.

Regulatory Compliance Filing

The company submitted its compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 on 14.04.2026. The certificate was signed by Dhananjaya Alli, Executive Director (DIN: 00610909), and addressed to BSE Limited at Phiroze Jeejeebhoy Towers, Mumbai.

Registrar Confirmation

Aarthi Consultants Private Limited, serving as the company's Registrar and Transfer Agent, provided the underlying certificate confirming compliance with dematerialization requirements. The registrar, holding SEBI Registration No. INR000000379, certified completion of all required actions for the period from 01.01.2026 to 31.03.2026.

Compliance Actions Completed

The registrar confirmed execution of the following mandatory procedures:

• Mutilation and cancellation of physical security certificates forwarded by depository participants
• Substitution of depository names as registered owners in company records
• Verification that dematerialized securities are listed on appropriate stock exchanges
• Completion of all actions within the stipulated 15-day timeframe

Certificate Details

The compliance certificate confirms that Vista Pharmaceuticals Limited has met all regulatory requirements for dematerialization processes during the specified quarter. The certificate was issued by Jagan Mohan Gobburi, Compliance Officer at Aarthi Consultants Private Limited, dated 03.04.2026.

This filing represents Vista Pharmaceuticals Limited's ongoing commitment to regulatory compliance and transparent reporting to stock exchange authorities and stakeholders.